The NCCN Guidelines for Palliative Care provide interdisciplinary recommendations on palliative care for patients with cancer. The NCCN Guidelines are intended to provide guidance to the primary oncology team on the integration of palliative care into oncology. The NCCN Palliative Care Panel's recommendations seek to ensure that each patient experiences the best quality of life possible throughout the illness trajectory. Accordingly, the NCCN Guidelines outline best practices for screening, assessment, palliative care interventions, reassessment, and after-death care.

  • 1.

    BergerAPortenoyRWeissmanD eds. Practice and Principles of Supportive Oncology. Philadelphia: Lippincott-Raven; 1998.

  • 2.

    DoyleDHanksGMacDonaldNe eds. Oxford Textbook of Palliative Medicine. Oxford: Oxford University; 1998.

  • 3.

    EmanuelLvon GuntenCFDF eds. The Education for Physicians on End-of-Life Care (EPEC) Curriculum. Princeton: The Robert Wood Johnson Foundation; 1999.

    • Search Google Scholar
    • Export Citation
  • 4.

    CleelandCSZhaoFChangVT. The symptom burden of cancer: evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer2013;119:43334340.

    • Search Google Scholar
    • Export Citation
  • 5.

    SmithTJTeminSAlesiER. American Society of Clinical Oncology Provisional Clinical Opinion: the integration of palliative care into standard oncology care. J Clin Oncol2012;30:880887.

    • Search Google Scholar
    • Export Citation
  • 6.

    TemelJSGreerJAMuzikanskyA. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med2010;363:733742.

    • Search Google Scholar
    • Export Citation
  • 7.

    DiverEO'ConnorOGarrettL. Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement. Gynecol Oncol2013;129:332335.

    • Search Google Scholar
    • Export Citation
  • 8.

    RichardsDMTanikellaRAroraG. Percutaneous endoscopic gastrostomy in cancer patients: predictors of 30-day complications, 30-day mortality, and overall mortality. Dig Dis Sci2013;58:768776.

    • Search Google Scholar
    • Export Citation
  • 9.

    SalpeterSRMalterDSLuoEJ. Systematic review of cancer presentations with a median survival of six months or less. J Palliat Med2012;15:175185.

    • Search Google Scholar
    • Export Citation
  • 10.

    Communicating with Patients on Health Care Evidence. Institute of Medicine; 2012. Available at: http://www.iom.edu/Global/Perspectives/2012/Evidence.aspx. Accessed May 17 2013.

    • Search Google Scholar
    • Export Citation
  • 11.

    NovelliWDHalvorsonGCSantaJ. Recognizing an Opinion: Findings From the IOM Evidence Communication Innovation CollaborativeJAMA2012;308:15311532.

    • Search Google Scholar
    • Export Citation
  • 12.

    FreeloveRWallingAD. Pancreatic cancer: diagnosis and management. Am Fam Physician2006;73:485492.

  • 13.

    GuarneriVContePF. The curability of breast cancer and the treatment of advanced disease. Eur J Nucl Med Mol Imaging2004;31Suppl 1:S149161.

    • Search Google Scholar
    • Export Citation
  • 14.

    PientaKJSmithDC. Advances in prostate cancer chemotherapy: a new era begins. CA Cancer J Clin2005;55:300318; quiz 323–305.

  • 15.

    PrommerE. Guidelines for the Use of Palliative Chemotherapy. AAHPM Bulletin2004;5:213.

  • 16.

    AjaniJA. Evolving chemotherapy for advanced gastric cancer. Oncologist2005;10Suppl 3:4958.

  • 17.

    BrownJThorpeHNappV. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. J Clin Oncol2005;23:74177427.

    • Search Google Scholar
    • Export Citation
  • 18.

    SilvestriGARiveraMP. Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. Chest2005;128:39753984.

    • Search Google Scholar
    • Export Citation
  • 19.

    ChenABCroninAWeeksJC. Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol2013;31:558564.

    • Search Google Scholar
    • Export Citation
  • 20.

    ZafarSYMalinJLGrambowSC. Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study. Cancer2013;119:854862.

    • Search Google Scholar
    • Export Citation
  • 21.

    HigginsonIJFinlayIGGoodwinDM. Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers?J Pain Symptom Manage2003;25:150168.

    • Search Google Scholar
    • Export Citation
  • 22.

    KinzbrunnerBM. Hospice: what to do when anti-cancer therapy is no longer appropriate, effective, or desired. Semin Oncol1994;21:792798.

    • Search Google Scholar
    • Export Citation
  • 23.

    Trajkovic-VidakovicMde GraeffAVoestEETeunissenSC. Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients. Crit Rev Oncol Hematol2012;84:130148.

    • Search Google Scholar
    • Export Citation
  • 24.

    YennurajalingamSKwonJHUrbauerDL. Consistency of symptom clusters among advanced cancer patients seen at an outpatient supportive care clinic in a tertiary cancer center. Palliat Support Care2013;11:473480.

    • Search Google Scholar
    • Export Citation
  • 25.

    Van LanckerAVelgheAVan HeckeA. Prevalence of symptoms in older cancer patients receiving palliative care: a systematic review and meta-analysis. J Pain Symptom Manage2014;47:90104.

    • Search Google Scholar
    • Export Citation
  • 26.

    FerrellBLevyMHPaiceJ. Managing pain from advanced cancer in the palliative care setting. Clin J Oncol Nurs2008;12:575581.

  • 27.

    TemelJSPirlWFLynchTJ. Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer. Clin Lung Cancer2006;7:241249.

    • Search Google Scholar
    • Export Citation
  • 28.

    Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med1999;159:321340.

    • Search Google Scholar
    • Export Citation
  • 29.

    DeCampMMJr.MentzerSJSwansonSJSugarbakerDJ. Malignant effusive disease of the pleura and pericardium. Chest1997;112:291S295S.

  • 30.

    DySMLorenzKANaeimA. Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea. J Clin Oncol2008;26:38863895.

    • Search Google Scholar
    • Export Citation
  • 31.

    SwansonNMirzaIWijesingheNDevlinG. Primary percutaneous balloon pericardiotomy for malignant pericardial effusion. Catheter Cardiovasc Interv2008;71:504507.

    • Search Google Scholar
    • Export Citation
  • 32.

    XueDAbernethyAP. Management of dyspnea in advanced lung cancer: recent data and emerging concepts. Curr Opin Support Palliat Care2010;4:8591.

    • Search Google Scholar
    • Export Citation
  • 33.

    DySMApostolCC. Evidence-based approaches to other symptoms in advanced cancer. Cancer J2010;16:507513.

  • 34.

    Ben-AharonIGafter-GviliAPaulM. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol2008;26:23962404.

    • Search Google Scholar
    • Export Citation
  • 35.

    Ben-AharonIGafter-GviliALeiboviciLStemmerSM. Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis. Acta Oncol2012;51:9961008.

    • Search Google Scholar
    • Export Citation
  • 36.

    ClemensKEQuednauIKlaschikE. Is there a higher risk of respiratory depression in opioid-naive palliative care patients during symptomatic therapy of dyspnea with strong opioids?J Palliat Med2008;11:204216.

    • Search Google Scholar
    • Export Citation
  • 37.

    GomutbutraPO'RiordanDLPantilatSZ. Management of Moderate-to-Severe Dyspnea in Hospitalized Patients Receiving Palliative Care. J Pain Symptom Manage2012.

    • Search Google Scholar
    • Export Citation
  • 38.

    JenningsALDaviesANHigginsJP. A systematic review of the use of opioids in the management of dyspnoea. Thorax2002;57:939944.

  • 39.

    SimonSTHigginsonIJBoothS. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev2010:CD007354.

    • Search Google Scholar
    • Export Citation
  • 40.

    CoynePJViswanathanRSmithTJ. Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea. J Pain Symptom Manage2002;23:157160.

    • Search Google Scholar
    • Export Citation
  • 41.

    SmithTJCoynePFrenchW. Failure to accrue to a study of nebulized fentanyl for dyspnea: lessons learned. J Palliat Med2009;12:771772.

  • 42.

    SimonSTKoskerogluPGaertnerJVoltzR. Fentanyl for the relief of refractory breathlessness: a systematic review. J Pain Symptom Manage2013;46:874886.

    • Search Google Scholar
    • Export Citation
  • 43.

    HuiDXuAFrisbee-HumeS. Effects of prophylactic subcutaneous fentanyl on exercise-induced breakthrough dyspnea in cancer patients: a preliminary double-blind, randomized, controlled trial. J Pain Symptom Manage2014;47:209217.

    • Search Google Scholar
    • Export Citation
  • 44.

    JensenDAlsuhailAViolaR. Inhaled Fentanyl Citrate Improves Exercise Endurance During High-Intensity Constant Work Rate Cycle Exercise in Chronic Obstructive Pulmonary Disease. J Pain Symptom Manage2011.

    • Search Google Scholar
    • Export Citation
  • 45.

    KawabataMKaneishiK. Continuous subcutaneous infusion of compound oxycodone for the relief of dyspnea in patients with terminally ill cancer: a retrospective study. Am J Hosp Palliat Care2013;30:305311.

    • Search Google Scholar
    • Export Citation
  • 46.

    BackINJenkinsKBlowerABeckhellingJ. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med2001;15:329336.

    • Search Google Scholar
    • Export Citation
  • 47.

    DavisMPFursteA. Glycopyrrolate: a useful drug in the palliation of mechanical bowel obstruction. J Pain Symptom Manage1999;18:153154.

    • Search Google Scholar
    • Export Citation
  • 48.

    HughesAWilcockACorcoranR. Audit of three antimuscarinic drugs for managing retained secretions. Palliat Med2000;14:221222.

  • 49.

    WildiersHMentenJ. Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage2002;23:310317.

  • 50.

    WildiersHDhaenekintCDemeulenaereP. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. J Pain Symptom Manage2009;38:124133.

    • Search Google Scholar
    • Export Citation
  • 51.

    GrumDFOsborneLR. Central anticholinergic syndrome following glycopyrrolate. Anesthesiology1991;74:191193.

  • 52.

    WingardDW. Glycopyrrolate and the central anticholinergic syndrome. Anesthesiology1991;75:11251126.

  • 53.

    MirakhurRKDundeeJW. Glycopyrrolate: pharmacology and clinical use. Anaesthesia1983;38:11951204.

  • 54.

    Death Rattle and Oral Secretions2nd ed.End of Life / Palliative Education Resource Center (EPERC); Available at: http://www.eperc.mcw.edu/EPERC/FastFactsIndex/ff_109.htm. Accessed May 20 2013.

    • Search Google Scholar
    • Export Citation
  • 55.

    GalbraithSFaganPPerkinsP. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage2010;39:831838.

    • Search Google Scholar
    • Export Citation
  • 56.

    AbernethyAPMcDonaldCFFrithPA. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet2010;376:784793.

    • Search Google Scholar
    • Export Citation
  • 57.

    NavaSFerrerMEsquinasA. Palliative use of non-invasive ventilation in end-of-life patients with solid tumours: a randomised feasibility trial. Lancet Oncol2013;14:219227.

    • Search Google Scholar
    • Export Citation
  • 58.

    HuiDMorgadoMChisholmG. High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial. J Pain Symptom Manage2013;46:463473.

    • Search Google Scholar
    • Export Citation
  • 59.

    KumarNBKaziASmithT. Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment. Curr Treat Options Oncol2010;11:107117.

    • Search Google Scholar
    • Export Citation
  • 60.

    LavianoAMeguidMMInuiA. Therapy insight: Cancer anorexia-cachexia syndrome: when all you can eat is yourself. Nat Clin Pract Oncol2005;2:158165.

    • Search Google Scholar
    • Export Citation
  • 61.

    OberholzerRHopkinsonJBBaumannK. Psychosocial Effects of Cancer Cachexia: A Systematic Literature Search and Qualitative Analysis. J Pain Symptom Manage2012.

    • Search Google Scholar
    • Export Citation
  • 62.

    MartinLBirdsellLMacdonaldN. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol2013;31:15391547.

    • Search Google Scholar
    • Export Citation
  • 63.

    Pascual LopezARoque i FigulsMUrrutia CuchiG. Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome. J Pain Symptom Manage2004;27:360369.

    • Search Google Scholar
    • Export Citation
  • 64.

    Ruiz GarciaVLopez-BrizECarbonell SanchisR. Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev2013;3:CD004310.

    • Search Google Scholar
    • Export Citation
  • 65.

    YavuzsenTDavisMPWalshD. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol2005;23:85008511.

    • Search Google Scholar
    • Export Citation
  • 66.

    MillerSMcNuttLMcCannMAMcCorryN. Use of corticosteroids for anorexia in palliative medicine: a systematic review. J Palliat Med2014;17:482485.

    • Search Google Scholar
    • Export Citation
  • 67.

    NavariRMBrennerMC. Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial. Support Care Cancer2010;18:951956.

    • Search Google Scholar
    • Export Citation
  • 68.

    MantovaniGMaccioAMadedduC. Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia. Oncologist2010;15:200211.

    • Search Google Scholar
    • Export Citation
  • 69.

    MaccioAMadedduCGramignanoG. A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life. Gynecol Oncol2012;124:417425.

    • Search Google Scholar
    • Export Citation
  • 70.

    WalshDNelsonKAMahmoudFA. Established and potential therapeutic applications of cannabinoids in oncology. Support Care Cancer2003;11:137143.

    • Search Google Scholar
    • Export Citation
  • 71.

    StrasserFLuftnerDPossingerK. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol2006;24:33943400.

    • Search Google Scholar
    • Export Citation
  • 72.

    JatoiAWindschitlHELoprinziCL. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol2002;20:567573.

    • Search Google Scholar
    • Export Citation
  • 73.

    IsenringEACapraSBauerJD. Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer2004;91:447452.

    • Search Google Scholar
    • Export Citation
  • 74.

    RavascoPMonteiro-GrilloIVidalPMCamiloME. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol2005;23:14311438.

    • Search Google Scholar
    • Export Citation
  • 75.

    TrenthamK. Palliative Care. In: MarianMRobertsS eds. Clinical Nutrition for Oncology Patients. Sudbury, MA: Jones and Bartlett Publishers LLC; 2010.

    • Search Google Scholar
    • Export Citation
  • 76.

    BaldwinCSpiroAMcGoughC. Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial. J Hum Nutr Diet2011;24:431440.

    • Search Google Scholar
    • Export Citation
  • 77.

    BaldwinCSpiroAAhernREmeryPW. Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst2012;104:371385.

    • Search Google Scholar
    • Export Citation
  • 78.

    AugustDAHuhmannMB. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr2009;33:472500.

    • Search Google Scholar
    • Export Citation
  • 79.

    McCannRMHallWJGroth-JunckerA. Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. JAMA1994;272:12631266.

    • Search Google Scholar
    • Export Citation
  • 80.

    WeinerRSKramerBSClamonGH. Effects of intravenous hyperalimentation during treatment in patients with small-cell lung cancer. J Clin Oncol1985;3:949957.

    • Search Google Scholar
    • Export Citation
  • 81.

    WinterSM. Terminal nutrition: framing the debate for the withdrawal of nutritional support in terminally ill patients. Am J Med2000;109:723726.

    • Search Google Scholar
    • Export Citation
  • 82.

    BrueraEHuiDDalalS. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol2013;31:111118.

    • Search Google Scholar
    • Export Citation
  • 83.

    SchwartzbergL. Chemotherapy-induced nausea and vomiting: state of the art in 2006. J Support Oncol2006;4:38.

  • 84.

    ShoemakerLKEstfanBInduruRWalshTD. Symptom management: an important part of cancer care. Cleve Clin J Med2011;78:2534.

  • 85.

    HoltDWVolansGN. Gastrointestinal symptoms of digoxin toxicity. Br Med J1977;2:704.

  • 86.

    HwangWJTsaiJJ. Acute phenytoin intoxication: causes, symptoms, misdiagnoses, and outcomes. Kaohsiung J Med Sci2004;20:580585.

  • 87.

    HardyJRO'SheaAWhiteC. The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer. J Pain Symptom Manage2010;40:111116.

    • Search Google Scholar
    • Export Citation
  • 88.

    GrallaRJItriLMPiskoSE. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med1981;305:905909.

    • Search Google Scholar
    • Export Citation
  • 89.

    BuzdarAUEsparzaLNataleR. Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study. Am J Clin Oncol1994;17:417421.

    • Search Google Scholar
    • Export Citation
  • 90.

    TanLLiuJLiuX. Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting. J Exp Clin Cancer Res2009;28:131.

    • Search Google Scholar
    • Export Citation
  • 91.

    NavariRMGraySEKerrAC. Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial. J Support Oncol2011;9:188195.

    • Search Google Scholar
    • Export Citation
  • 92.

    GrunbergSMStevensonLLRussellCAMcDermedJE. Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting. J Clin Oncol1989;7:11371141.

    • Search Google Scholar
    • Export Citation
  • 93.

    MartyMPouillartPSchollS. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med1990;322:816-821.

    • Search Google Scholar
    • Export Citation
  • 94.

    KrisMGGrallaRJClarkRA. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial. Cancer1987;60:28162822.

    • Search Google Scholar
    • Export Citation
  • 95.

    AaproMSPleziaPMAlbertsDS. Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide. J Clin Oncol1984;2:466471.

    • Search Google Scholar
    • Export Citation
  • 96.

    NavariRMEinhornLHPassikSD. A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group study. Support Care Cancer2005;13:529534.

    • Search Google Scholar
    • Export Citation
  • 97.

    HermanTSEinhornLHJonesSE. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med1979;300:12951297.

    • Search Google Scholar
    • Export Citation
  • 98.

    MoritaTTakigawaCOnishiH. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial. J Pain Symptom Manage2005;30:96103.

    • Search Google Scholar
    • Export Citation
  • 99.

    SlatkinNE. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis. J Support Oncol2007;5:19.

    • Search Google Scholar
    • Export Citation
  • 100.

    MamtaniRCiminoA. A primer of complementary and alternative medicine and its relevance in the treatment of mental health problems. Psychiatr Q2002;73:367381.

    • Search Google Scholar
    • Export Citation
  • 101.

    ManskyPJWallerstedtDB. Complementary medicine in palliative care and cancer symptom management. Cancer J2006;12:425431.

  • 102.

    MarchioroGAzzarelloGVivianiF. Hypnosis in the treatment of anticipatory nausea and vomiting in patients receiving cancer chemotherapy. Oncology2000;59:100104.

    • Search Google Scholar
    • Export Citation
  • 103.

    DavisMPHallerbergG. A systematic review of the treatment of nausea and/or vomiting in cancer unrelated to chemotherapy or radiation. J Pain Symptom Manage2010;39:756767.

    • Search Google Scholar
    • Export Citation
  • 104.

    BeckerGGalandiDBlumHE. Peripherally acting opioid antagonists in the treatment of opiate-related constipation: a systematic review. J Pain Symptom Manage2007;34:547565.

    • Search Google Scholar
    • Export Citation
  • 105.

    ManciniIBrueraE. Constipation in advanced cancer patients. Support Care Cancer1998;6:356364.

  • 106.

    DhingraLShukEGrossmanB. A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease. Palliat Med2013;27:447456.

    • Search Google Scholar
    • Export Citation
  • 107.

    American Pain Socitey. Principles ofAnalgesic use in the treatment of acute pain and cancer pain (ed 5th). Glenview, IL: American Pain Society; 2003.

    • Search Google Scholar
    • Export Citation
  • 108.

    CandyBJonesLLarkinPJ. Laxatives for the management of constipation in people receiving palliative care. Cochrane Database Syst Rev2015;5:CD003448.

    • Search Google Scholar
    • Export Citation
  • 109.

    HawleyPHByeonJJ. A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer. J Palliat Med2008;11:575581.

    • Search Google Scholar
    • Export Citation
  • 110.

    PortenoyRKThomasJMoehl BoatwrightML. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage2008;35:458468.

    • Search Google Scholar
    • Export Citation
  • 111.

    ThomasJKarverSCooneyGA. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med2008;358:23322343.

  • 112.

    WebsterLCheyWDTackJ. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation. Aliment Pharmacol Ther2014;40:771779.

    • Search Google Scholar
    • Export Citation
  • 113.

    CheyWDWebsterLSostekM. Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med2014;370:23872396.

  • 114.

    JamalMMAdamsABJansenJPWebsterLR. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain. Am J Gastroenterol2015;110:725732.

    • Search Google Scholar
    • Export Citation
  • 115.

    LacyBELevyLC. Lubiprostone: a novel treatment for chronic constipation. Clin Interv Aging2008;3:357364.

  • 116.

    CheyWDLemboAJLavinsBJ. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol2012;107:17021712.

    • Search Google Scholar
    • Export Citation
  • 117.

    ChangLLemboAJLavinsBJ. The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials. Aliment Pharmacol Ther2014;40:13021312.

    • Search Google Scholar
    • Export Citation
  • 118.

    WeinbergDSSmalleyWHeidelbaughJJ. American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome. Gastroenterology2014;147:11461148.

    • Search Google Scholar
    • Export Citation
  • 119.

    PDQ® Gastrointestinal Complications. Bethesda, MD: National Cancer Institute; Available at: http://cancer.gov/cancertopics/pdq/supportivecare/gastrointestinalcomplications/HealthProfessional. Accessed March 17 2015.

    • Search Google Scholar
    • Export Citation
  • 120.

    BensonAB3rdAjaniJACatalanoRB. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol2004;22:29182926.

    • Search Google Scholar
    • Export Citation
  • 121.

    AndreyevJRossPDonnellanC. Guidance on the management of diarrhoea during cancer chemotherapy. Lancet Oncol2014;15:e447460.

  • 122.

    PessiMAZilemboNHaspingerER. Targeted therapy-induced diarrhea: A review of the literature. Crit Rev Oncol Hematol2014;90:165179.

  • 123.

    FrancescuttiVMillerASatchidanandY. Management of bowel obstruction in patients with stage IV cancer: predictors of outcome after surgery. Ann Surg Oncol2013;20:707714.

    • Search Google Scholar
    • Export Citation
  • 124.

    FeuerDJBroadleyKE. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev2000:CD001219.

    • Search Google Scholar
    • Export Citation
  • 125.

    KaneishiKKawabataMMoritaT. Olanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstruction. J Pain Symptom Manage2012;44:604607.

    • Search Google Scholar
    • Export Citation
  • 126.

    PorzioGAielliFVernaL. Can malignant bowel obstruction in advanced cancer patients be treated at home?Support Care Cancer2011;19:431433.

    • Search Google Scholar
    • Export Citation
  • 127.

    MercadanteSFerreraPVillariPMarrazzoA. Aggressive pharmacological treatment for reversing malignant bowel obstruction. J Pain Symptom Manage2004;28:412416.

    • Search Google Scholar
    • Export Citation
  • 128.

    ZelekLLavalGAsselainB. Somatostatin analogs for malignant bowel obstruction resulting from peritoneal carcinomatosis. J Clin Oncol2013;31:25192520.

    • Search Google Scholar
    • Export Citation
  • 129.

    BergerJLesterPRodriguesL. Medical Therapy of Malignant Bowel Obstruction With Octreotide, Dexamethasone, and Metoclopramide. Am J Hosp Palliat Care2015.

    • Search Google Scholar
    • Export Citation
  • 130.

    MercadanteSCasuccioAMangioneS. Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. J Pain Symptom Manage2007;33:217223.

    • Search Google Scholar
    • Export Citation
  • 131.

    MercadanteSPorzioG. Octreotide for malignant bowel obstruction: twenty years after. Crit Rev Oncol Hematol2012;83:388392.

  • 132.

    CurrowDCClarkKCartmillJ. A multi-site fixed dose parallel arm double-blind placebo controlled block randomised trial of the addition of infusional octreotide or placebo to regular ranitidine and dexamethasone for the evaluation of vomiting associated with bowel obstruction at the end of life. [Abstract]. 2012 ASCO Annual Meeting: American Society for Clinical Oncology; 2012:TPS9153. Available at: http://meetinglibrary.asco.org/content/101301-114.

    • Search Google Scholar
    • Export Citation
  • 133.

    BaronTH. Interventional palliative strategies for malignant bowel obstruction. Curr Oncol Rep2009;11:293297.

  • 134.

    BrooksbankMAGamePAAshbyMA. Palliative venting gastrostomy in malignant intestinal obstruction. Palliat Med2002;16:520526.

  • 135.

    MuckeMMochamatCuhlsH. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev2015;5:CD006788.

    • Search Google Scholar
    • Export Citation
  • 136.

    EscalanteCPMeyersCReubenJM. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J2014;20:814.

    • Search Google Scholar
    • Export Citation
  • 137.

    GongSShengPJinH. Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. PLoS One2014;9:e84391.

    • Search Google Scholar
    • Export Citation
  • 138.

    MoraskaARSoodADakhilSR. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol2010;28:36733679.

    • Search Google Scholar
    • Export Citation
  • 139.

    HoveyEde SouzaPMarxG. Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy. Support Care Cancer2014;22:12331242.

    • Search Google Scholar
    • Export Citation
  • 140.

    Jean-PierrePMorrowGRRoscoeJA. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer2010;116:35133520.

    • Search Google Scholar
    • Export Citation
  • 141.

    PaleshOGRoscoeJAMustianKM. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol2010;28:292298.

    • Search Google Scholar
    • Export Citation
  • 142.

    SavardJIversHVillaJ. Natural course of insomnia comorbid with cancer: an 18-month longitudinal study. J Clin Oncol2011;29:35803586.

  • 143.

    PaleshOAldridge-GerryAUlusakaryaA. Sleep disruption in breast cancer patients and survivors. J Natl Compr Canc Netw2013;11:15231530.

    • Search Google Scholar
    • Export Citation
  • 144.

    YennurajalingamSChisholmGPallaSL. Self-reported sleep disturbance in patients with advanced cancer: Frequency, intensity, and factors associated with response to outpatient supportive care consultation: a preliminary report. Palliat Support Care2013:19.

    • Search Google Scholar
    • Export Citation
  • 145.

    JohnsMW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep1991;14:540545.

  • 146.

    PayneRJHierMPKostKM. High prevalence of obstructive sleep apnea among patients with head and neck cancer. J Otolaryngol2005;34:304311.

    • Search Google Scholar
    • Export Citation
  • 147.

    SternTPAuckleyD. Obstructive sleep apnea following treatment of head and neck cancer. Ear Nose Throat J2007;86:101103.

  • 148.

    Antonescu-TurcuAParthasarathyS. CPAP and bi-level PAP therapy: new and established roles. Respir Care2010;55:12161229.

  • 149.

    AllenRPChenCGarcia-BorregueroD. Comparison of pregabalin with pramipexole for restless legs syndrome. N Engl J Med2014;370:621631.

  • 150.

    BassettiCLBornaticoFFuhrP. Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial. Swiss Med Wkly2011;141:w13274.

    • Search Google Scholar
    • Export Citation
  • 151.

    Ferini-StrambiLAarskogDPartinenM. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial. Sleep Med2008;9:874881.

    • Search Google Scholar
    • Export Citation
  • 152.

    KaplanPWAllenRPBuchholzDWWaltersJK. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep1993;16:717723.

    • Search Google Scholar
    • Export Citation
  • 153.

    ManconiMFerriRZucconiM. Pramipexole versus ropinirole: polysomnographic acute effects in restless legs syndrome. Mov Disord2011;26:892895.

    • Search Google Scholar
    • Export Citation
  • 154.

    MontplaisirJNicolasADenesleRGomez-MancillaB. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology1999;52:938943.

    • Search Google Scholar
    • Export Citation
  • 155.

    OertelWHStiasny-KolsterKBergtholdtB. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study). Mov Disord2007;22:213219.

    • Search Google Scholar
    • Export Citation
  • 156.

    TrenkwalderCGarcia-BorregueroDMontagnaP. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry2004;75:9297.

    • Search Google Scholar
    • Export Citation
  • 157.

    WaltersASOndoWGDreykluftT. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord2004;19:14141423.

    • Search Google Scholar
    • Export Citation
  • 158.

    BergerAM. Update on the state of the science: sleep-wake disturbances in adult patients with cancer. Oncol Nurs Forum2009;36:E165177.

    • Search Google Scholar
    • Export Citation
  • 159.

    HarsoraPKessmannJ. Nonpharmacologic management of chronic insomnia. Am Fam Physician2009;79:125130.

  • 160.

    JungquistCRO'BrienCMatteson-RusbyS. The efficacy of cognitive-behavioral therapy for insomnia in patients with chronic pain. Sleep Med2010;11:302309.

    • Search Google Scholar
    • Export Citation
  • 161.

    HowellDOliverTKKeller-OlamanS. Sleep disturbance in adults with cancer: a systematic review of evidence for best practices in assessment and management for clinical practice. Ann Oncol2013.

    • Search Google Scholar
    • Export Citation
  • 162.

    GarlandSNCarlsonLEStephensAJ. Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol2014;32:449457.

    • Search Google Scholar
    • Export Citation
  • 163.

    KimSWShinISKimJM. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. Psychiatry Clin Neurosci2008;62:7583.

    • Search Google Scholar
    • Export Citation
  • 164.

    StewartSA. The effects of benzodiazepines on cognition. J Clin Psychiatry2005;66Suppl 2:913.

  • 165.

    US Food and Drug Administration. Zolpidem Containing Products: Drug Safety Communication: FDA Requires Lower Recommended Doses. 2013. Available at: http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm334738.htm. Accessed March 3 2014.

    • Search Google Scholar
    • Export Citation
  • 166.

    BrueraEFainsingerRMacEachernTHansonJ. The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report. Pain1992;50:7577.

    • Search Google Scholar
    • Export Citation
  • 167.

    2011 Physicians' Desk Reference (ed 65). Montvale, NJ: PDR Network, LLC; 2010.

  • 168.

    Diagnostic and statistical manual of mental disorders (ed 4th). Washington, DC: American Psychiatric Association; 1994.

  • 169.

    BushSHKanjiSPereiraJL. Treating an Established Episode of Delirium in Palliative Care: Expert Opinion and Review of the Current Evidence Base With Recommendations for Future Development. J Pain Symptom Manage2014.

    • Search Google Scholar
    • Export Citation
  • 170.

    IrwinSAPirrelloRDHirstJM. Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practice. J Palliat Med2013;16:423435.

    • Search Google Scholar
    • Export Citation
  • 171.

    HosieADavidsonPMAgarM. Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: a systematic review. Palliat Med2013;27:486498.

    • Search Google Scholar
    • Export Citation
  • 172.

    de la CruzMFanJYennuS. The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center. Support Care Cancer2015.

    • Search Google Scholar
    • Export Citation
  • 173.

    BreitbartWAliciY. Evidence-based treatment of delirium in patients with cancer. J Clin Oncol2012;30:12061214.

  • 174.

    ZimmermanKMSalowMSkarfLM. Increasing anticholinergic burden and delirium in palliative care inpatients. Palliat Med2014;28:335341.

  • 175.

    DevlinJWRobertsRJFongJJ. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med2010;38:419427.

    • Search Google Scholar
    • Export Citation
  • 176.

    GroverSMattooSKGuptaN. Usefulness of Atypical Antipsychotics and Choline Esterase Inhibitors in Delirium: A Review. Pharmacopsychiatry2011.

    • Search Google Scholar
    • Export Citation
  • 177.

    MaherARMaglioneMBagleyS. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA2011;306:13591369.

    • Search Google Scholar
    • Export Citation
  • 178.

    LacasseHPerreaultMMWilliamsonDR. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. Ann Pharmacother2006;40:19661973.

    • Search Google Scholar
    • Export Citation
  • 179.

    JacobsonSA. Delirium in the elderly. Psychiatr Clin North Am1997;20:91110.

  • 180.

    CaraceniANanniOMaltoniM. Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer2000;89:11451149.

    • Search Google Scholar
    • Export Citation
  • 181.

    KehlKA. Treatment of terminal restlessness: a review of the evidence. J Pain Palliat Care Pharmacother2004;18:530.

  • 182.

    WeeksJCCookEFO'DaySJ. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA1998;279:17091714.

    • Search Google Scholar
    • Export Citation
  • 183.

    SmithTJDowLAViragoEA. A pilot trial of decision aids to give truthful prognostic and treatment information to chemotherapy patients with advanced cancer. J Support Oncol2011;9:7986.

    • Search Google Scholar
    • Export Citation
  • 184.

    WrightAAZhangBRayA. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA2008;300:16651673.

    • Search Google Scholar
    • Export Citation
  • 185.

    SmithTJSwisherK. Telling the truth about terminal cancer. JAMA1998;279:17461748.

  • 186.

    MackJWWolfeJCookEF. Hope and prognostic disclosure. J Clin Oncol2007;25:56365642.

  • 187.

    LiuPHLandrumMBWeeksJC. Physicians' propensity to discuss prognosis is associated with patients' awareness of prognosis for metastatic cancers. J Palliat Med2014;17:673682.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 527 527 85
PDF Downloads 127 127 29
EPUB Downloads 0 0 0